dr. Siebe Loontiens

A morphomolecular study of 175 'USP6‐associated neoplasms’ : the USP6 fusion partner strongly depends on morphology and location

Fleur Cordier (UGent) , Jo Van Dorpe (UGent) , Raf Sciot, Uta Flucke, Joost Van Gorp, Maria Debiec‐Rychter, Sarah Van Belle, Siebe Loontiens (UGent) , Joni Van der Meulen (UGent) , Bram Van Gaever (UGent) , et al.

(2025) HISTOPATHOLOGY.

Add to list

Pediatric PLAG1‐rearranged fibromyxoid spindle cell tumor : an emerging distinct entity or a fibroblastic (‘non‐lipogenic’) pattern of lipoblastoma?

Fleur Cordier (UGent) , Siebe Loontiens (UGent) , Joni Van der Meulen (UGent) , Liesbeth Ferdinande (UGent) and David Creytens (UGent)

(2025) PATHOLOGY INTERNATIONAL. 75(11). p.593-595

Add to list

Journal Article
A1
open access

A challenging case of an epithelioid haemangioma of bone with novel FOS::ANKRD28 gene fusion

Fleur Cordier (UGent) , Liesbeth Ferdinande (UGent) , Siebe Loontiens (UGent) , Joni Van der Meulen (UGent) , Jo Van Dorpe (UGent) and David Creytens (UGent)

(2025) PATHOLOGY. 57(7). p.953-955

Add to list

Journal Article
A1
open access

Atypical spindle cell/pleomorphic lipomatous tumour : a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour

Fleur Cordier (UGent) , Tony G Kleijn, Thomas Mentzel, Uta Flucke, Joost van Gorp, Liesbeth Ferdinande (UGent) , Sarah Van Belle, Siebe Loontiens (UGent) , Joni Van der Meulen (UGent) , Jo Van Dorpe (UGent) , et al.

(2025) HISTOPATHOLOGY. 87(2). p.197-205

Add to list

Journal Article
A1
open access

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

Areeba Patel, Kirsten Göbel, Sebastian Ille, Felix Hinz, Natalie Schoebe, Henri Bogumil, Jochen Meyer, Michelle Brehm, Helin Kardo, Daniel Schrimpf, et al.

(2025) NATURE MEDICINE. 31. p.1567-1577

Add to list

Journal Article
A1
open access

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

Pieter-Jan Volders (UGent) , Philippe Aftimos, Franceska Dedeurwaerdere, Geert Martens, Jean-Luc Canon, Gabriela Beniuga, Guy Froyen, Jacques Van Huysse, Rebecca De Pauw, Hans Prenen, et al.

(2025) NPJ PRECISION ONCOLOGY. 9(1).

Add to list

Journal Article
A1
open access

Revealing RB1 loss in an emerging entity : report of two cases of PRRX1-rearranged mesenchymal tumours

Fleur Cordier (UGent) , Sharareh Fadaei, Liesbeth Ferdinande (UGent) , Frederick Dochy, Lieve Vanwalleghem, Karolien Van Den Bossche, Siebe Loontiens (UGent) , Joni Van der Meulen (UGent) , Nadine Van Roy (UGent) , Jo Van Dorpe (UGent) , et al.

(2025) JOURNAL OF CLINICAL PATHOLOGY. 78(3). p.154-160

Add to list

Journal Article
A1
open access

MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma

Elina Fredlund, Stina Andersson, Elien Hilgert (UGent) , Ezequiel Monferrer, Guadalupe Álvarez-Hernán, Sinan Karakaya, Siebe Loontiens (UGent) , Jan Willem Bek (UGent) , Tomas Gregor, Estelle Lecomte, et al.

(2024) SCIENCE ADVANCES. 10(25).

Add to list

Journal Article
A1
open access

A challenging case of an intraosseous composite hemangioendothelioma of the occipital bone with YAP1::FOXR1 fusion

Fleur Cordier (UGent) , Liesbeth Ferdinande (UGent) , Siebe Loontiens (UGent) , Joni Van der Meulen (UGent) , Jo Van Dorpe (UGent) and David Creytens (UGent)

(2024) GENES CHROMOSOMES & CANCER. 63(12).

Add to list

Journal Article
A1
open access

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Charlotte Fieuws, Joni Van der Meulen (UGent) , Kristiaan Proesmans (UGent) , Emiel De Jaeghere (UGent) , Siebe Loontiens (UGent) , Jo Van Dorpe (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) and Kathleen Claes (UGent)

(2024) NPJ PRECISION ONCOLOGY. 8(1).

Academic Bibliography

dr. Siebe Loontiens

A morphomolecular study of 175 'USP6‐associated neoplasms’ : the USP6 fusion partner strongly depends on morphology and location

Pediatric PLAG1‐rearranged fibromyxoid spindle cell tumor : an emerging distinct entity or a fibroblastic (‘non‐lipogenic’) pattern of lipoblastoma?

A challenging case of an epithelioid haemangioma of bone with novel FOS::ANKRD28 gene fusion

Atypical spindle cell/pleomorphic lipomatous tumour : a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

Revealing RB1 loss in an emerging entity : report of two cases of PRRX1-rearranged mesenchymal tumours

MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma

A challenging case of an intraosseous composite hemangioendothelioma of the occipital bone with YAP1::FOXR1 fusion

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Contents

Support

Contact